Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Potassium channel-blocking immunosuppressants from Merck & Co.

July 29, 1998

Novavax extends option agreement with Cantab

July 29, 1998

Scientists report success in achieving tolerance in transplantation models

July 22, 1998

Lisofylline development timetable readjusted, marketing agreements revised

July 22, 1998

Promising phase II results reported for BTI-322 in GVHD

July 21, 1998

Ribi acquires new adjuvant technology from U of Nebraska

July 21, 1998

Human vaccination study demonstrates potential of oral and nasal MaxVax

July 20, 1998

Promising immunosuppressive activity reported for KF-20444

July 17, 1998

In vitro and in vivo studies with VX-497 reported at transplant congress

July 17, 1998

Pasteur Merieux Connaught, Cistron Biotechnology collaborate on vaccine adjuvant development

July 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...